Application and effectiveness evaluation of enhanced recovery after surgery in perioperative period for patients with liver cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100053814

Enrollment

Unknown

Registered

2021-11-29

Start date

2021-12-01

Completion date

Unknown

Last updated

2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ablation of liver cancer

Interventions

ERAS group:execute ERAS management measures in perioperative period

Control group:execute conventional management measures in perioperative period

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Confirmed by pathological results or clinically diagnosed as liver cancer; 2. Intraoperative ablation under general anesthesia; 3. According to the results of factor analysis, select patients who are prone to postoperative pain, postoperative fever and other observation indicators.

Exclusion criteria

Exclusion criteria: 1. Patients undergoing combined therapy (combined liver resection, assisted laparoscopy, etc.); 2. Lack of complete imaging data; 3. The operation is interrupted due to various uncontrollable factors.

Design outcomes

Primary

Measure	Time frame
Postoperative pain;	—

Secondary

Measure	Time frame
Postoperative complications;Postoperative hospital stay;Postoperative hospitalization costs;Postoperative anal exhaust time;	—

Countries

China

Contacts

Public ContactLi Kai

The Third Affiliated Hospital of Sun Yat-Sen University

DAIFEI182@163.com+86 18216054995

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026